As of 2025-08-23, the Relative Valuation of Ginkgo Bioworks Holdings Inc (DNA) is (119.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 12.55 USD, the upside of Ginkgo Bioworks Holdings Inc based on Relative Valuation is -1052.0%.
The range of the Relative Valuation is (100.58) - (124.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 22.0x | 19.1x |
| Forward P/E multiples | 17.7x - 28.3x | 23.0x |
| Fair Price | (100.58) - (124.76) | (119.48) |
| Upside | -901.4% - -1094.1% | -1052.0% |
| Date | P/E |
| 2025-08-22 | -2.21 |
| 2025-08-21 | -2.07 |
| 2025-08-20 | -2.04 |
| 2025-08-19 | -2.10 |
| 2025-08-18 | -2.43 |
| 2025-08-15 | -2.32 |
| 2025-08-14 | -2.27 |
| 2025-08-13 | -2.34 |
| 2025-08-12 | -2.04 |
| 2025-08-11 | -2.09 |
| 2025-08-08 | -2.17 |
| 2025-08-07 | -2.37 |
| 2025-08-06 | -2.46 |
| 2025-08-05 | -2.52 |
| 2025-08-04 | -2.40 |
| 2025-08-01 | -2.15 |
| 2025-07-31 | -2.31 |
| 2025-07-30 | -2.27 |
| 2025-07-29 | -2.28 |
| 2025-07-28 | -2.46 |
| 2025-07-25 | -2.46 |
| 2025-07-24 | -2.63 |
| 2025-07-23 | -2.49 |
| 2025-07-22 | -2.35 |
| 2025-07-21 | -1.99 |
| 2025-07-18 | -1.78 |
| 2025-07-17 | -1.72 |
| 2025-07-16 | -1.69 |
| 2025-07-15 | -1.66 |
| 2025-07-14 | -1.75 |
| 2025-07-11 | -1.76 |
| 2025-07-10 | -1.90 |
| 2025-07-09 | -1.95 |
| 2025-07-08 | -1.96 |
| 2025-07-07 | -2.00 |
| 2025-07-03 | -2.24 |
| 2025-07-02 | -2.23 |
| 2025-07-01 | -2.00 |
| 2025-06-30 | -1.98 |
| 2025-06-27 | -1.67 |
| 2025-06-26 | -1.69 |
| 2025-06-25 | -1.64 |
| 2025-06-24 | -1.62 |
| 2025-06-23 | -1.50 |
| 2025-06-20 | -1.51 |
| 2025-06-18 | -1.51 |
| 2025-06-17 | -1.51 |
| 2025-06-16 | -1.62 |
| 2025-06-13 | -1.58 |
| 2025-06-12 | -1.64 |